SCHEMBL4596777

SCHEMBL4596777

Clc1ccc(-c2cccc3c2OC(CCc2ccccc2)C3)c(Cl)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT2 Q8IXJ6 2/20 0.49
AQP1 P29972 2/20 0.48
CYP1A2 P05177 2/20 0.41
CYP2D6 P10635 2/20 0.41
CYP2C9 P11712 2/20 0.41
NPC1 O15118 1/20 0.41
CYP2C19 P33261 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CXCR2 P25025 1/20 0.38
DRD4 P21917 2/20 0.37
CYP3A4 P08684 2/20 0.37
PRKAB2 O43741 1/20 0.36
PRKAG1 P54619 1/20 0.36
PRKAA2 P54646 1/20 0.36
PRKAA1 Q13131 1/20 0.36
PRKAG3 Q9UGI9 1/20 0.36
PRKAG2 Q9UGJ0 1/20 0.36
PRKAB1 Q9Y478 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4596728 0.91 SIRT2 (0.52) SIRT2AQP1CYP1A2CYP2D6CYP2C9
SCHEMBL4596403 0.89 SIRT2 (0.48) SIRT2AQP1CYP1A2CYP2D6CYP2C9
SCHEMBL4596987 0.88 SIRT2 (0.55) SIRT2AQP1CYP1A2CYP2D6CYP2C9
SCHEMBL4595085 0.88 SIRT2 (0.54) SIRT2AQP1CYP1A2CYP2D6CYP2C9
SCHEMBL4596108 0.85 AQP1 (0.51) SIRT2AQP1CYP1A2CYP2D6CYP2C9
SCHEMBL6047946 0.84 SIRT2 (0.46) SIRT2AQP1CXCR2DRD4CYP3A4
SCHEMBL4596679 0.83 SIRT2 (0.50) SIRT2AQP1CYP1A2CYP2D6CYP2C9
SCHEMBL4226179 0.82 AQP1 (0.70) AQP1CYP1A2PRKAB2PRKAG1PRKAA2
SCHEMBL6047969 0.80 CYP3A4 (0.44) SIRT2DRD4CYP3A4PRKAB2PRKAG1
SCHEMBL4233789 0.80 AQP1 (0.43) AQP1NPC1RAB9APRKAB2PRKAG1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1874750-A1 DIHYDROBENZOFURANYL ALKANAMINE DERIVATIVES AS 5HT2C AGONISTS Wyeth Incoporated (US) 2008-01-09 EP disclosed